|
Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006
|
Vercauteren, J.; Derdelinckx, I.; Sasse, A.; Bogaert, M.; Ceunen, H.; De Roo, A.; De Wit, S.; Deforche, K.; Echahidi, F.; Fransen, K.; Goffard, J. C.; Goubau, P.; Goudeseune, E.; Yombi, J. C.; Lacor, P.; Liesnard, C.; Moutschen, M.; Pierard, D.; Rens, R.; Schrooten, Y.; Vaira, D.; Van den Heuvel, A.; Van der Gucht, B.; Van Ranst, M.; Van Wijngaerden, E.; Vandercam, B.; Vekemans, M.; Verhofstede, C.; Clumeck, N.; Vandamme, A. M.; Van Laethem, K.
|
AIDS Research and Human Retroviruses |
2008
|
Article
|
|
Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database
|
Ruelle, J.; Roman, F.; Vandenbroucke, A. T.; Lambert, C.; Fransen, K.; Echahidi, F.; Piérard, D.; Verhofstede, C.; Van Laethem, K.; Delforge, M. L.; Vaira, D.; Schmit, J. C.; Goubau, P.
|
BMC Infectious Diseases |
2008
|
Article-E
|